
About Anagenex
Anagenex is a Healthcare company based in San Francisco (United States) founded in 2019 by Nicolas Tilmans. Drug discovery services are manufactured by Anagenex in San Francisco. Anagenex has raised $30 million across 2 funding rounds from investors including Khosla Ventures, Catalio Capital Management and Lux Capital. The company has 23 employees. Its chief executive, as recorded, is Nicolas Tilmans. Its website anagenex.com draws about 10 thousand monthly visits. Anagenex offers products and services including AI Drug Discovery Platform. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery. Its legal entity is ANAGENEX, INC. Its competitors include Formation Bio, AbSci and BigHat; 3 of its 3 listed competitors have raised funding.
Company details
Anagenex was founded in 2019 and is headquartered in San Francisco, United States. Drug discovery services are provided through manufacturing processes in the biotechnology sector. Operations center on supporting pharmaceutical research and development needs. The company is led by Nicolas Tilmans, who serves as Founder and CEO. Focus remains on efficient service delivery for industry clients in the region.
- Headquarters San Francisco, United States
- Employees 23
- Founders Nicolas Tilmans
- SectorsHealthcare
- Website anagenex.com
- Social LinkedIn X
- Legal Name Anagenex, Inc
- Total Equity Funding$30M (USD)
in 2 rounds
- Latest Funding Round$30M (USD), Series A
Jun 2022
- InvestorsKhosla Ventures
& 5 more
- Employee Count23
Products & Services of Anagenex
Anagenex offers a comprehensive portfolio of products and services, including AI Drug Discovery Platform.
Platform tests billions of molecules for disease treatments and AI refinement.
Funding Insights of Anagenex
Anagenex has successfully raised a total of $30M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $30 million completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $30M
- Total Rounds 2
- Last Round Series A β $30M
- Investors Count 6
All 2 funding rounds of Anagenex with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2022 | $30M | Series A | β | Catalio Capital Management | |
| Jun 2020 | Seed | β | Lux Capital | β |
6 investors in total: 6 institutional.
Investors in Anagenex
Anagenex has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include Khosla Ventures, Catalio Capital Management and Lux Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital is provided to biomedical technology startups. | cataliocapital.com | New York, United States | ||
Seed and early-stage technology companies are funded by Lux Capital. | luxcapital.com | Menlo Park, United States | ||
Early-stage startups are funded by this venture capital firm. | 2004 | khoslaventures.com | Menlo Park, United States | |
Provider of venture capital investments across planetary, human, and economic health | obvious.com | San Francisco, United States | ||
Venture capital firm investing in AI & life science sectors | airstreet.com | St. Peter Port, United Kingdom | ||
Early-stage venture capital firm investing in AI, healthcare, and tech sectors. | menlovc.com |
Investor details for Anagenex
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Anagenex
6 people are tracked at Anagenex (2 in leadership, 1 in board & advisors, 3 in team); the tracked headcount is 23.
| Name | Role | Group |
|---|---|---|
Nicolas Tilmans | Founder & CEO | Leadership |
Lashadric Grady | Associate Director, DEL Chemistry | Leadership |
Tito A. Serafini | Independent Board Member | Board & advisors |
Joe Franklin | SVP, Early Discovery | Team |
Erica Chong Ng | Research Associate, Chemistry | Team |
Kimberly Barnash | Principal Scientist, Biochemistry | Team |
Complete people profiles for Anagenex
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Anagenex
3 dated milestones of Anagenex across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Anagenex is founded.
- Funding First funding round.
- Funding Latest funding round, Series A, of $30.0M.
Competitors of Anagenex
Anagenex has 3 listed competitors in our database, 3 of them funded. They include Formation Bio, AbSci and BigHat.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| formation.bio | 2016 | New York, United States | $608.25M | AI-powered drug discovery platform for various diseases | ||
| absci.com | 2011 | Vancouver, United States | $227.56M | 256 | AI-based technology is used for recombinant protein production in therapeutics. | |
| bighatbio.com | 2019 | San Carlos, United States | $148.41M | Antibody therapies are developed through machine learning and synthetic biology. |
Detailed competitors of Anagenex
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Anagenex
The website of Anagenex (anagenex.com) receives about 10.4K visits a month.
- Monthly visits10.4K
▲ 531.1% vs previous month
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Anagenex (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Anagenex
Complete news archive for Anagenex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anagenex
Anagenex was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Anagenex is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Nicolas Tilmans is the CEO of Anagenex, as recorded in our data. They have also founded this company.
Anagenex is a funded company, having raised a total of $30M across 2 funding rounds to date.
Anagenex has 23 employees.
Anagenex was founded in 2019 and is headquartered in San Francisco, United States. Drug discovery services are provided through manufacturing processes in the biotechnology sector. Operations center on supporting pharmaceutical research and development needs. The company is led by Nicolas Tilmans, who serves as Founder and CEO. Focus remains on efficient service delivery for industry clients in the region.
Anagenex's top competitors include Formation Bio, BigHat and AbSci.
Anagenex offers AI Drug Discovery Platform.
Anagenex has 6 investors. Key investors include Khosla Ventures, Catalio Capital Management, Lux Capital, Obvious Ventures, and Air Street Capital.
Anagenex operates through Anagenex, Inc.
